1.Efficacy and Tolerability of Moclobemide Compared with Amitriptyline in Dysthymic Disorder.
Min Soo LEE ; Jong Won NAM ; Ji Hyun CHA ; Young Ku KIM ; Seung Ho RYU
Journal of the Korean Society of Biological Psychiatry 1999;6(1):96-101
BACKGROUND: Since dysthymia begins in late childhood or adolescence and has a chronic course, long-term pharmacotherapy may be required. New generation antidepressant, moclobemide, with more acceptable side effect profiles, is effective in the treatment of dysthymia. The main objective of this study was to determine whether they exhibit comparable efficacy and tolerability in dysthymia to amitriptyline. METHOD AND MATERIALS: The efficacy and tolerability of the moclobemide and amitriptyline, were compared in a eight-week single-centre double-blind study in patients(n=37) with dysthymia using he HAMD-17, the Clinical Global Impression Scale(CGI), the Montgomery-Asberg Depression Rating Scale(MADRS), Efficacy Index-Therapeutic Index(EITE), 4-point Index Side Effect Scale(4-PISES), and Efficacy Index-Side Effect Scale(EISE). RESULTS: A total of 37 patients entered the study, 19 were randomly assigned to the moclobemide group and 18 to be amitriptyline group. Demographic and illness characteristics were similar in both groups. There were no significant difference between two groups at the total 17-HDRS score, the HAMD-17% improvement, the total MADRS score, CGI response, and the EITE. In the comparison of EISE between two groups, the scores of the moclobemide group were relatively lower than the amitriptylinen group in full treatment. And the differences were significant(moclobemide group 1.39+/-0.61 ; amitriptyline group 2.00+/-0.85, p<.001). At the 4-PISE. There was no serious or treatment threatening side effects. And there was no specific difference in side effects between two groups. The moclobemide group reported higher EIR scores than the amitriptyline group at every follow up day, but the differences were not significant. And there was no significant differences in the scores of five HRQOL subcategories which is compared between two groups at every follow up days. CONCLUSIONS: In terms of 17-HDRS and MADRS, moclobemide and amitriptyline are equally effective at least in allevating dysthymic symptoms. But moclobemide tended to be less troubling and better tolerated than amitriptyline. Therefore, moclobemide treatment can be used as a safe, and higher satisfactory treatment strategy for the dysthymia.
Adolescent
;
Amitriptyline*
;
Depression
;
Double-Blind Method
;
Drug Therapy
;
Dysthymic Disorder*
;
Follow-Up Studies
;
Humans
;
Moclobemide*
2.Nefazodone and Associated Perceptual Disturbance : A Report of Four Cases.
Ji Yun KIM ; Hyoung Seok SONG ; Bang Hyun CHO ; Yong Ku KIM
Journal of the Korean Society of Biological Psychiatry 1999;6(2):259-263
Nefazodone, a newer antidepressant is a phenylpiperazine derivative that inhibits the reuptake of both norepinephrine and serotonin, and antagonizes 5-HT2A and alpha1 adrenergic receptors. Compared with SSRIs nefazodone caused the fewer activating symptoms, adverse gastrointestinal effects(nausea, diarrhea, anorexia) and adverse effects of sexual function, but is associated with the more dizziness, dry mouth, constipation, visual disturbances and confusion. We report on 4 cases of visual disturbances and hallucinations in patients taking nefazodone. 1) Nefazodone, as a 5-HT2A antagonist, might induce visual disturbances. 2) mCPP, metabolite of nefazodone might contribute to the hallucination through action on 5-HT receptor. 3) Dopaminergic enhancing activity of nefazodone might cause hallucination. The case report raises the possibility that dose-related perceptual disturbances may exist with nefazodone. The fact emphasizes the need to pay close attention to all possible drug interactions, particularly in patients treated with multiple psychoactive agents, older patients, and patients with decreased hepatic function.
Constipation
;
Diarrhea
;
Dizziness
;
Drug Interactions
;
Hallucinations
;
Humans
;
Mouth
;
Norepinephrine
;
Psychotropic Drugs
;
Receptors, Adrenergic
;
Serotonin
;
Serotonin 5-HT2 Receptor Antagonists
3.Lower Serum Cholesterol Level is Associated with More Serious Injury in psychiatric Patients with Suicide Attempt.
Yong Ku KIM ; Heon Jeong LEE ; Ji Yeon KIM ; Min Soo LEE ; So Hyun CHOI
Journal of the Korean Society of Biological Psychiatry 1999;6(2):227-234
An association of low total cholesterol in blood with psychiatric diseases and suicidal behavior has been suggested. As part of an attempt to further explore this relationship, we examine first, whether serum cholesterol levels in psychiatric patients with suicidal attempt would be lower than in non-suicidal psychiatric inpatients or normal controls, second, whether such significant difference of cholesterol levels would be present when the diagnostic groups are analyzed separately, third whether low cholesterol level would be associated with a history of serious suicidal attempts, and finally, whether low cholesterol level in suicide attempters is as state or a trait marker. We determined the serum cholesterol levels in 231 patients admitted to an emergency room following an suicidal attempt, in the same numbers of age-, sex- and diagnosis-matched non-suicidal psychiatric controls, and in the same numbers of age-, sex matched normal controls. The seriousness of an attempt was divided into 5 grades according to the degree of the resulting medical injury. Total cholesterol levels in suicide attempters were significantly lower compared with both psychiatric and normal controls, when sex, age, and nutritional status(i.e., body mass index) were controlled for. This significant relationship was observed in major depressive disorders and personality disorders, but not in schizophrenia and bipolar type I disorders. The severity of suicide by a lowering of blood cholesterol was related to the magnitude of the cholesterol reduction. After treatment of their psychiatric ailments, the cholesterol levels in suicide attempters were significantly increased. This result suggests that low cholesterol level in psychiatric patients might be a potential biological marker of suicide risk. It is hypothesized that low cholesterol levels is associated with the suicide by modifying the serotonin metabolism, the production of interleukin-2 and melatonin metabolism in psychiatric patients.
Biomarkers
;
Cholesterol*
;
Depression
;
Depressive Disorder, Major
;
Emergency Service, Hospital
;
Humans
;
Inpatients
;
Interleukin-2
;
Melatonin
;
Metabolism
;
Personality Disorders
;
Schizophrenia
;
Serotonin
;
Suicide*
4.Are age, anthropometry and components of metabolic syndrome-risk factors interrelated with lower urinary tract symptoms in patients with erectile dysfunction? A prospective study.
Jae-Seung PAICK ; Ji-Hyun YANG ; Soo-Woong KIM ; Ja-Hyeon KU
Asian Journal of Andrology 2007;9(2):213-220
AIMTo evaluate the effects of metabolic profiles on lower urinary tract symptoms (LUTS) in men with erectile dysfunction (ED).
METHODSA total of 75 impotent men aged 25-75 years old (mean 58.1 years) were included in the study on a prospective basis. Patients were evaluated with a complete history, physical examination, anthropometry and metabolic profiles. LUTS were assessed using the International Prostate Symptom Score (IPSS).
RESULTSOverall, there was no correlation between the IPSS and continuous parameters. However, when continuous variables were categorized, some parameters were significantly associated with LUTS. Patients with triglyceride level of 150 mg/dL or higher had more severe symptoms than those with triglyceride levels less than 150 mg/dL (19.4 +/- 2.4 vs. 14.3 +/- 1.1, P = 0.033). When 40 mg/dL was chosen as the high-density lipoprotein (HDL)-cholesterol cut-off level, the IPSS was significantly different between the two groups divided by 40 mg/dL (19.4 +/- 2.6 for HDL-cholesterol < 40 mg/dL vs. 14.4 +/- 1.0 for HDL-cholesterol = or > 40 mg/dL, P = 0.042). The area under the receiver operating characteristic curve (AUROCC) of triglyceride was 65.7% (95% confidence interval [CI], 52.6%-82.3%; P = 0.034) for severe LUTS. However, the AUROCC for 'HDL-cholesterol' was not significant (area, 65.4%; 95% CI, 48.2%-82.7%; P = 0.062). No other factors were determined to be significant in this regard.
CONCLUSIONThe results of the present study indicate that some metabolic profiles might influence LUTS in men with ED.
Adult ; Aged ; Aging ; Body Mass Index ; Erectile Dysfunction ; etiology ; pathology ; physiopathology ; Humans ; Male ; Metabolic Syndrome ; etiology ; Middle Aged ; Prostate ; pathology ; Risk Factors ; Triglycerides ; blood ; Urologic Diseases ; etiology ; pathology ; physiopathology
5.Current Status of Three-Dimensional Printing Inks for Soft Tissue Regeneration.
Ji Eun KIM ; Soo Hyun KIM ; Youngmee JUNG
Tissue Engineering and Regenerative Medicine 2016;13(6):636-646
Recently, three-dimensional (3D) printing technologies have become an attractive manufacturing process, which is called additive manufacturing or rapid prototyping. A 3D printing system can design and fabricate 3D shapes and geometries resulting in custom 3D scaffolds in tissue engineering. In tissue regeneration and replacement, 3D printing systems have been frequently used with various biomaterials such as natural and synthetic polymers. In tissue engineering, soft tissue regeneration is very difficult because soft tissue has the properties of high elasticity, flexibility and viscosity which act as an obstacle when creating a 3D structure by stacking layer after layer of biomaterials compared to hard tissue regeneration. To overcome these limitations, many studies are trying to fabricate constructs with a very similar native micro-environmental property for a complex biofunctional scaffold with suitable biological and mechanical parameters by optimizing the biomaterials, for example, control the concentration and diversification of materials. In this review, we describe the characteristics of printing biomaterials such as hydrogel, synthetic polymer and composite type as well as recent advances in soft tissue regeneration. It is expected that 3D printed constructs will be able to replace as well as regenerate defective tissues or injured functional tissues and organs.
Biocompatible Materials
;
Elasticity
;
Hydrogel
;
Ink*
;
Pliability
;
Polymers
;
Printing, Three-Dimensional*
;
Regeneration*
;
Tissue Engineering
;
Viscosity
6.Association of Adiponectin 45T/G Polymorphism with Diabetic Cardiovascular Complications in Korean Type 2 Diabetes.
Myeong Jin JI ; Eu Jeong KU ; Tae Keun OH ; Hyun Jeong JEON
Journal of Korean Medical Science 2018;33(17):e124-
BACKGROUND: Adiponectin is an adipokine that regulates lipid and glucose metabolism and has been shown to have anti-inflammatory and anti-atherogenic effects. It also plays an important role in the development of cardiovascular disease (CVD). METHODS: This study evaluated the association between adiponectin 45T/G polymorphism and cardiovascular complication in type 2 diabetes in Koreans. RESULTS: The present study included 758 patients with type 2 diabetes. The distribution of the adiponectin 45T/G polymorphism was 3.56% (n = 27) for GG, 42.35% (n = 321) for TG, and 54.09% (n = 410) for TT in patients with type 2 diabetes. The prevalence of CVD was significantly higher in subjects with the GG + TG genotype compared to those with the TT genotype (17.5% vs. 9.8%, P = 0.002). The G allele was associated with a higher risk of CVD (P = 0.002). CONCLUSION: Our findings suggest that the adiponectin 45T/G polymorphism is associated with diabetic cardiovascular complication in type 2 diabetes.
Adipokines
;
Adiponectin*
;
Alleles
;
Cardiovascular Diseases
;
Genotype
;
Glucose
;
Humans
;
Metabolism
;
Prevalence
7.An Obese Pregnant Woman with Type 2 Diabetes Whose One-Day Insulin Requirements Were 1,000 IU
Sang Hyun JU ; Ji Min KIM ; Kyong Hye JOUNG ; Hyun Jin KIM ; Bon Jeong KU
Korean Journal of Obesity 2016;25(3):154-158
Insulin resistance in patients with diabetes mellitus may be aggravated by various causes, including infection, obesity, and medications known to affect insulin sensitivity. During pregnancy, insulin resistance can be the result of hormones secreted by the placenta. Blood glucose control during pregnancy is important in preventing obstetric complications including miscarriage, congenital malformations, and macrosomia. We report a case of severe insulin resistance in an obese diabetic pregnant woman whose one-day insulin requirements were up to 1,000 IU.
Abortion, Spontaneous
;
Blood Glucose
;
Diabetes Mellitus
;
Female
;
Humans
;
Insulin Resistance
;
Insulin
;
Obesity
;
Placenta
;
Pregnancy
;
Pregnant Women
8.A case of combined adrenocorticotropic hormone(ACTH) and growth hormone(GH) deficiency.
Hyung Seon RYEU ; Seung Sig SIM ; Mann JUNG ; Chang Hyun PARK ; Chan Woong PARK ; Young Mi LEE ; Seok Bae CHEON ; Sang Ku KANG ; Yong MOON ; Ji Woon KIM
Korean Journal of Medicine 1993;45(4):522-526
No abstract available.
9.Cardiovascular collapse due to right heart failure following ethanol sclerotherapy: a case report.
Jun Young JO ; Ji Hyun CHIN ; Pyung Hwan PARK ; Seung Woo KU
Korean Journal of Anesthesiology 2014;66(5):388-391
Ethanol sclerotherapy for the treatment of low-flow vascular malformations can cause catastrophic cardiopulmonary complications, including pulmonary embolism and pulmonary hypertension, that can result in right heart failure and fatal arrhythmias, leading to death. We here report a case of abrupt cardiovascular collapse that developed immediately following ethanol sclerotherapy in 31-year-old female patient who had a large arteriovenous malformation in her leg. Anesthesiologists should be aware of the fatal cardiopulmonary complications that are associated with ethanol sclerotherapy and consider the use of invasive hemodynamic monitoring, such as pulmonary artery pressure monitoring, when large doses of ethanol are required.
Adult
;
Arrhythmias, Cardiac
;
Arteriovenous Malformations
;
Ethanol*
;
Female
;
Heart Arrest
;
Heart Failure*
;
Hemodynamics
;
Humans
;
Hypertension, Pulmonary
;
Leg
;
Pulmonary Artery
;
Pulmonary Embolism
;
Sclerotherapy*
;
Vascular Malformations
10.Pregnancy Rate Following Superovulation with Intrauterine Insemination in Infertile Patients.
Young Min CHOI ; Ji Young LEE ; Seung Yup KU ; Chang Suk SUH ; Seok Hyun KIM ; Jung Gu KIM ; Shin Yong MOON ; Jin Yong LEE
Korean Journal of Obstetrics and Gynecology 1999;42(12):2787-2791
OBJECTIVES: To investigate the efficiency of superovulation with intrauterine insemination (IUI) in infertile patients. MATERIALS AND METHODS: Seventy-two cycles of superovulation with IUI in 48 infertile couples in which gonadotrophins were used for hyperstimulation were analysed retrospectively. RESULTS: Overall clinical pregnancy rate was 33.3% per cycle and 45.8% per patient. By the infertility factor, patients with endometriosis showed the lowest pregnancy rate (10%). Cumulative pregnancy rate (CPR), obtained by life-table analysis, increased as the number of cycles increased: 25.0% for one cycle, 33.3% for two cycle, 40% for three cycle and 50% for more than four cycle. CONCLUSIONS: Superovulation with IUI is an effective treatment modality in patients with subfecundity, and is worth while trying prior to in vitro fertilization procedure in those patients.
Endometriosis
;
Family Characteristics
;
Female
;
Fertility
;
Fertilization in Vitro
;
Humans
;
Infertility
;
Insemination*
;
Pregnancy Rate*
;
Pregnancy*
;
Retrospective Studies
;
Superovulation*